Pacira Pharma (PCRX) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Pacira Pharma (PCRX) Reports In-Line Q1 EPS

Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results

May 3, 2018 8:00 AM EDT

-- EXPAREL® net product sales of $74.0 million up 9% over prior year first quarter ---- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced consolidated financial results for the first quarter ended March 31, 2018.

2018 is off to a terrific start with EXPAREL daily sales volumes accelerating from 6 percent in January to 15 percent in March, as well as a recently expanded label that now includes interscalene brachial plexus block, said Dave Stack, chairman and chief executive officer of Pacira Pharmaceuticals. As... More